Biophytis(BPTS) - 2022 Q4 - Annual Report

Exhibit 99.1 Press release Biophytis regains compliance with NASDAQ minimum bid price requirement About BIOPHYTIS Biophytis SA is a clinical-stage biotechnology company specialized in the development of therapeutics that are aimed at slowing the degenerative processes associated with aging and improving functional outcomes for patients suffering from age-related diseases, including severe respiratory failure in patients suffering from COVID-19. Sarconeos (BIO101), our leading drug candidate, is a small mole ...